News & Opinion
Top 10 Innovations
Image of the Day
The Scientist University
Research Products Blog
Putting the Brakes on SARS-CoV-2: Neutralizing Antibodies
The Scientist Creative Services Team | Jul 6, 2020
Experts will discuss potential neutralizing antibodies currently under investigation for SARS-CoV-2 treatment.
World’s Largest Cell and Gene Therapy Plant Opens
Catherine Offord | Apr 10, 2018
Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.
CAR-T Therapies Get $1 Billion Boost
Bob Grant | Jul 1, 2015
The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.
Who Owns CRISPR?
Jenny Rood | Apr 3, 2015
With one US patent awarded and many other applications under consideration for the popular genome-editing technology, companies are adopting multiple strategies to navigate the complex intellectual property landscape.
The CAR T-Cell Race
Vicki Brower | Apr 1, 2015
Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.
The Second Coming of RNAi
Eric Bender | Sep 1, 2014
Now showing clinical progress against liver diseases, the gene-silencing technique begins to fulfill some of its promises.
Virus Found in Sf9 Cell Line
Kerry Grens | May 22, 2014
A government lab finds a novel virus present in cell lines used for therapeutic production that were thought to be virus-free.
Wrestling with Recurrent Infections
Gayatri Vedantam and Glenn S. Tillotson | May 1, 2011
is evolving more robust toxicity, repeatedly attacking its victims, and driving the search for alternative therapies to fight the infection.